Ratnakar Securities Pvt. Ltd.

AARTI PHARMALABS LTD.

NSE : AARTIPHARMBSE : 543748ISIN CODE : INE0LRU01027Industry : Pharmaceuticals & DrugsHouse : Private

BSE739.809.55 (+1.31 %)

PREV CLOSE ( ) 730.25

OPEN PRICE ( ) 737.55

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 6978

TODAY'S LOW / HIGH ( )728.55 749.05

52 WK LOW / HIGH ( )380.65 837

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 22-11 2019

Management Info

Rashesh C Gogri - Chairman Narendra J Salvi - Managing Director

Registered Office

Address Plot No. 22/ C/1 & 22/ C/2,1st Phase, G. I. D. C.,Valsad,
Vapi,
Gujarat-396195

Phone 0260 2400467 / 09909994655

Email info@aartipharmalabs.com

Website www.aartipharmalabs.com

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

07Feb Aarti Pharmalabs informs about press r
Aarti Pharmalabs has informed that the extract of Standalone and Consoli..

28Jan Aarti Pharmalabs informs about confere
Aarti Pharmalabs has informed that the Earnings Conference Call for Inve..

28Jan Aarti Pharmalabs informs about board m
Aarti Pharmalabs has informed that the meeting of the Board of Directors..

13Jan Aarti Pharmalabs surges on entering in
Aarti Pharmalabs is currently trading at Rs. 682.95, up by 13.90 points..

10Jan Aarti Pharmalabs informs about certifi
Aarti Pharmalabs has informed that it enclosed a Certificate under Regul..

Financials

in Millions

	QTR Dec 24	ANNUAL 24
Net Profit	735.23	2006.5
Gross Profit	961.8	2745.2
Operating Profit	1269.26	3571.6
Net Sales	4709.47	15021.3

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE) 11108.20 (1.35%)	M.Cap ( in Cr)14251.70
Hester Biosciences (BSE) 1348.95 (4.82%)	M.Cap ( in Cr)1147.53
Sanofi India (BSE) 5587.85 (0.59%)	M.Cap ( in Cr)12869.17
Mankind Pharma (BSE) 2201.10 (1.46%)	M.Cap ( in Cr)90812.66
Concord Biotech (BSE) 1648.15 (1.80%)	M.Cap ( in Cr)17242.32

Shareholding Pattern

	FI/BANKS/INSURANCE	6.09%
	PROMOTERS	44.66%
	NON-INSTITUTION	36.33%
	MUTUAL FUNDS/UTI	3.93%
	GOVERNMENT	0.01%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Quant Healthcare Fu...	4.55
Quant Business Cycl...	1.57
Quant Value Fund-Reg(G)	1.14
Quant Flexi Cap Fund(G)	0.89
Motilal Oswal Nifty...	0.44
Quant Small Cap Fund(G)	0.28

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

AARTI PHARMALABS LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES